Bédard PJ - Search Results

1

Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.

Samadi P, Grégoire L, Rouillard C, Bédard PJ, Di Paolo T, Lévesque D. Samadi P, et al. Among authors: bedard pj. Ann Neurol. 2006 Feb;59(2):282-8. doi: 10.1002/ana.20738. Ann Neurol. 2006. PMID: 16437566

2

Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.

Bélanger N, Grégoire L, Bédard P, Di Paolo T. Bélanger N, et al. Endocrine. 2003 Jun;21(1):97-101. doi: 10.1385/endo:21:1:97. Endocrine. 2003. PMID: 12777709

3

Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems.

Samadi P, Grégoire L, Bédard PJ. Samadi P, et al. Among authors: bedard pj. Neuropharmacology. 2003 Dec;45(7):954-63. doi: 10.1016/s0028-3908(03)00249-1. Neuropharmacology. 2003. PMID: 14573388

4

Chronic treatment with small doses of cabergoline prevents dopa-induced dyskinesias in parkinsonian monkeys.

Bélanger N, Grégoire L, Hadj Tahar A, Bédard PJ. Bélanger N, et al. Among authors: bedard pj. Mov Disord. 2003 Dec;18(12):1436-41. doi: 10.1002/mds.10589. Mov Disord. 2003. PMID: 14673879

5

The opioid agonist morphine decreases the dyskinetic response to dopaminergic agents in parkinsonian monkeys.

Samadi P, Grégoire L, Bédard PJ. Samadi P, et al. Among authors: bedard pj. Neurobiol Dis. 2004 Jun;16(1):246-53. doi: 10.1016/j.nbd.2004.02.002. Neurobiol Dis. 2004. PMID: 15207281

6

Dyskinesias occur in response to saline and naltrexone alone after priming with combination of dopaminergic agents and naltrexone in the MPTP parkinsonian monkeys.

Samadi P, Grégoire L, Rouillard C, Bédard PJ. Samadi P, et al. Among authors: bedard pj. Neurobiol Dis. 2005 Jun-Jul;19(1-2):266-72. doi: 10.1016/j.nbd.2005.01.006. Neurobiol Dis. 2005. PMID: 15837582

7

Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys.

Samadi P, Grégoire L, Rassoulpour A, Guidetti P, Izzo E, Schwarcz R, Bédard PJ. Samadi P, et al. Among authors: bedard pj. Mov Disord. 2005 Jul;20(7):792-802. doi: 10.1002/mds.20596. Mov Disord. 2005. PMID: 15954116

8

Naltrexone in the short-term decreases antiparkinsonian response to l-Dopa and in the long-term increases dyskinesias in drug-naïve parkinsonian monkeys.

Samadi P, Grégoire L, Hadj Tahar A, Di Paolo T, Rouillard C, Bédard PJ. Samadi P, et al. Among authors: bedard pj. Neuropharmacology. 2005 Aug;49(2):165-73. doi: 10.1016/j.neuropharm.2005.02.009. Epub 2005 Mar 29. Neuropharmacology. 2005. PMID: 15996565

9

Opioids and motor complications in Parkinson's disease.

Samadi P, Bédard PJ, Rouillard C. Samadi P, et al. Among authors: bedard pj. Trends Pharmacol Sci. 2006 Oct;27(10):512-7. doi: 10.1016/j.tips.2006.08.002. Epub 2006 Sep 5. Trends Pharmacol Sci. 2006. PMID: 16908075

10

mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys.

Samadi P, Grégoire L, Morissette M, Calon F, Hadj Tahar A, Dridi M, Belanger N, Meltzer LT, Bédard PJ, Di Paolo T. Samadi P, et al. Among authors: bedard pj. Neurobiol Aging. 2008 Jul;29(7):1040-51. doi: 10.1016/j.neurobiolaging.2007.02.005. Epub 2007 Mar 13. Neurobiol Aging. 2008. PMID: 17353071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

184 results

Search Page